Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II

Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II

Background Nonvitamin K oral anticoagulants require dose adjustment based on kidney function.The most common estimate of kidney function employed in clinical practice is estimated glomerular filtration rate (eGFR); however, product monographs recommend the use of the Cockcroft‐Gault estimated creati...

Full description

Bibliographic Details
Main Authors: Ren Jie Robert Yao, DaJuanicia N. Holmes, Jason G. Andrade, Adeera Levin, Jonathan P. Piccini, Christopher B. Fordyce
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
nonvitamin K oral anticoagulant
ORBIT‐AF II
renal dose adjustment
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026605

Similar Items

Similar Items